Table 2 Crude and age-adjusted overall and gender-specific thyroid cancer prevalence (95% CI) among patients with thyroid nodules who underwent ultrasound guided fine needle aspiration (UG-FNA) biopsy between January 2011 and December 2015 in a tertiary hospital in Abu Dhabi, United Arab Emirates
Crude Cancer Prevalence % (95% CI) | ||||
|---|---|---|---|---|
Overall | Women | Men | p-value* | |
N (cancer/No cancer) | 44/392 | 34/333 | 10/59 | |
All thyroid nodules | 10.1 (7.5–13.3) | 9.3 (6.3–12.2) | 14.5 (6.2–22.8) | 0.186 |
Age (years) | ||||
18–29 years | 16.7 (6.7–26.6) | 15.2 (4.8–25.6) | 25.0 (0.0–55.0) | 0.493 |
30–39 years | 8.8 (3.6–14.0) | 8.3 (3.1–13.5) | 16.7 (0.0–46.5) | 0.482 |
40–49 years | 12.0 (6.5–17.6) | 11.0 (5.1–16.9) | 16.7 (1.8–31.6) | 0.441 |
50–59 years | 5.2 (0.2–10.2) | 5.0 (0.0–10.5) | 5.9 (0.0–17.1) | 0.885 |
≥ 60 years | 8.6 (1.4–15.8) | 6.8 (0.0–14.3) | 14.3 (0.0–32.6) | 0.386 |
Ethnicity** | ||||
UAE | 9.5 (3.6–15.4) | 7.7 (1.8–13.6) | 17.6 (0.0–35.8) | 0.204 |
Arabs | 10.4 (6.5–14.2) | 10.1 (5.9–14.3) | 11.6 (2.0–21.2) | 0.766 |
Far-East Asians | 16.7 (4.5–28.8) | 12.1 (1.0–23.3) | 66.7 (13.3–99.9) | 0.015 |
Caucasians | 15.4 (1.5–29.3) | 16.0 (1.6–30.4) | 0 | |
Age-adjusted Cancer Prevalence % (95% CI) | ||||
All thyroid nodules | 10.0 (7.7–12.8) | 9.0 (6.0–11.9) | 15.1 (6.5–23.8) | 0.117 |
Ethnicitya | ||||
UAE | 9.6 (3.6–15.6) | 7.7 (1.8–13.7) | 18.7 (0.0–37.9) | 0.166 |
Arabs | 10.0 (6.2–13.8) | 9.7 (5.5–13.8) | 10.9 (1.5–20.4) | 0.799 |
Far-East Asians | 16.8 (4.5–29.0) | 12.3 (1.0–23.6) | 65.1 (10.4–99.9) | 0.019 |
Caucasians | 16.3 (1.7–30.9) | 17.0 (1.8–32.1) | 0 | |